GLS and cancer: A number of drugs have been developed as glutaminase inhibitors (Katt and Cerione, 2014); among these, BPTES (bis-2-(5-phenylacetamido-1,3,4-thiadiazol-2-yl)ethyl sulfide) is an important inhibitor that has been shown to be active in a variety of cancer cells.